Medicare Enrolled

Dr. Mark Socinski, MD

Hematology & Oncology · Orlando, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2501 N ORANGE AVE STE 689, Orlando, FL 32804
4073032024
Registered in NPPES since 2006
NPI: 1740341726 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Socinski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Socinski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Socinski

Dr. Mark Socinski is a hematology & oncology specialist in Orlando, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Socinski performed 162 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Socinski received a total of $2,528,864 from 56 pharmaceutical and/or device companies across 1802 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Socinski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 162 Medicare services $2,528,864 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 128890 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
162
Medicare services
Bottom 11% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $96 $381
New patient office visit, complex (60-74 min) 21 $176 $660
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
18 $132 $534
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,528,864
Total received (2018-2024)
Avg $361,266/year across 7 years
Top 0% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
1,802
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$264,625
2023
$347,699
2022
$420,518
2021
$421,936
2020
$260,966
2019
$416,041
2018
$397,078

Payments by company (2024)

Janssen Biotech, Inc.
$76,989
AstraZeneca Pharmaceuticals LP
$69,977
JAZZ PHARMACEUTICALS INC.
$51,336
Regeneron Healthcare Solutions, Inc.
$21,272
F. Hoffmann-La Roche AG
$12,495
E.R. Squibb & Sons, L.L.C.
$8,032
Genentech USA, Inc.
$7,696
Mirati Therapeutics, Inc.
$6,152
TAIHO ONCOLOGY, INC.
$2,935
Gilead Sciences, Inc.
$2,888
Novocure Inc.
$2,625
PFIZER INC.
$1,440
Merck Sharp & Dohme LLC
$350
Pharmacosmos Therapeutics Inc.
$132
Janssen Scientific Affairs, LLC
$120
INTUITIVE SURGICAL, INC.
$88
TerSera Therapeutics LLC
$75
Lilly USA, LLC
$23
Top 3 companies account for 74.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$648,822
Genentech USA, Inc.
$306,151
JAZZ PHARMACEUTICALS INC.
$195,753
Lilly USA, LLC
$187,500
Janssen Biotech, Inc.
$149,523
Regeneron Healthcare Solutions, Inc.
$130,051
G1 Therapeutics, Inc.
$101,646
F. Hoffmann-La Roche AG
$92,522
Celgene Corporation
$72,934
E.R. Squibb & Sons, L.L.C.
$70,251
Eli Lilly and Company
$66,543
Jazz Pharmaceuticals Inc.
$65,397
Takeda Pharmaceuticals U.S.A., Inc.
$60,589
Bayer HealthCare Pharmaceuticals Inc.
$58,345
Merck Sharp & Dohme Corporation
$53,115
Mirati Therapeutics, Inc.
$38,378
Novartis Pharmaceuticals Corporation
$24,891
Blueprint Medicines Corporation
$20,095
GENZYME CORPORATION
$18,235
Amgen Inc.
$16,995
Merck Sharp & Dohme LLC
$14,675
Boehringer Ingelheim Pharmaceuticals, Inc.
$12,991
Janssen Scientific Affairs, LLC
$11,500
Genentech, Inc.
$9,734
EMD Serono, Inc.
$9,380
Gilead Sciences, Inc.
$8,684
AstraZeneca UK Limited
$7,218
NOVARTIS PHARMACEUTICALS CORPORATION
$6,187
AbbVie Inc.
$6,038
Foundation Medicine, Inc.
$5,505
PFIZER INC.
$5,445
Janssen Global Services, LLC
$5,360
SANOFI-AVENTIS U.S. LLC
$5,360
GlaxoSmithKline, LLC.
$5,200
Coherus Biosciences Inc.
$5,054
Daiichi Sankyo Inc.
$4,110
Eisai Inc.
$4,000
Chugai Pharmaceutical Co., Ltd.
$3,960
EISAI INC.
$2,975
TAIHO ONCOLOGY, INC.
$2,935
Novocure Inc.
$2,625
Regeneron Pharmaceuticals, Inc.
$2,534
Heron Therapeutics, Inc.
$2,085
Bayer Healthcare Pharmaceuticals Inc.
$1,750
Exelixis Inc.
$1,320
Mylan Inc.
$1,274
Boehringer Ingelheim International GmbH
$1,198
Acrotech Biopharma LLC
$816
Siemens Medical Solutions USA, Inc.
$604
Pharmacosmos Therapeutics Inc.
$132
BioNTech SE
$118
INTUITIVE SURGICAL, INC.
$88
BeiGene USA, Inc.
$83
TerSera Therapeutics LLC
$75
Spectrum Pharmaceuticals Inc.
$65
Clovis Oncology, Inc.
$50
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Avastin · BRUKINSA · Bevacizumab · CABOMETYX · COSELA · CYRAMZA · Cabometyx · Da Vinci Surgical System · ENHERTU · EXKIVITY · FOUNDATIONACT · FOUNDATIONONE · GAVRETO · GILOTRIF · Gavreto · IBRANCE · ILARIS · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MONOFERRIC · Non-Covered · Non-Covered Product · OFEV · OPDIVO · Optune Lua (NovoTTF-200T) · REBLOZYL · RETACRIT · RETEVMO · ROZLYTREK · RYBREVANT · Rubraca · SUSTOL · TABRECTA · TAGRISSO · TECENTRIQ · TEPMETKO · Tarceva · Tecentriq · Tecentriq Hybreza · Tepmetko · Tepotinib · Trodelvy · Udenyca · VERZENIO · Vitrakvi · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Orlando?
Compare hematology & oncology specialists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
49
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ASPIRE HEALTH PARTNERS
3.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Socinski is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Socinski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Socinski performed 123 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Socinski receive payments from pharmaceutical companies?
Yes. Dr. Socinski received a total of $2,528,864 from 56 companies across 1,802 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Socinski's costs compare to other hematology & oncology specialists in Orlando?
Dr. Socinski's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Socinski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →